Company profile
Acuitas Therapeutics
Global Leader in Lipid Nanoparticle (LNP) Delivery
- Industry
- Biotechnology
- Employees
- 77
- Headquarters
- Vancouver, British Columbia
- Founded
- 2009
- LinkedIn followers
- 16,316
- Office locations
- 1
Acuitas Therapeutics company summary
Acuitas Therapeutics is a company in the Biotechnology industry, headquartered in Vancouver, British Columbia, founded in 2009. On LinkedIn the company has around 77 employees and 16,316 followers.
What technology does Acuitas Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Acuitas Therapeutics
Acuitas Therapeutics Inc., the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, is a Vancouver-based company collaborating with pharmaceutical and biotech companies, academic researchers, and global health organizations to advance a broad range of medicines for a variety of diseases. Acuitas’s clinically validated LNP technology has enabled two approved products, as well as 33 clinical trials in the last three years, including: - COMIRNATY® for Covid-19 by Pfizer-BioNTech, - ONPATTRO® for transthyretin amyloidosis by Alnylam Pharmaceuticals, - First in-human proof of concept for genome base editing, and - First personalized CRISPR therapy. Today, Acuitas is advancing next-generation LNP to support a variety of modalities. These therapies include targeted LNP for extrahepatic and in vivo CAR-T cell therapies, epigenetic medicines to modulate gene expression without altering DNA, multivalent infectious disease vaccines, as well as oncology vaccines, including personalized cancer vaccines.
Where is Acuitas Therapeutics located?
Acuitas Therapeutics lists 1 location.
Compare companies similar to Acuitas Therapeutics
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Acuitas Therapeutics acuitastx.com | Biotechnology | 77 | 2009 | Vancouver, British Columbia |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about Acuitas Therapeutics
What does Acuitas Therapeutics do?
Acuitas Therapeutics Inc., the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, is a Vancouver-based company collaborating with pharmaceutical and biotech companies, academic researchers, and global health organizations to advance a broad range of medicines for a variety of diseases. Acuitas’s clinically validated LNP technology has enabled two approved products, as well as 33 clinical trials in the last three years, including: - COMIRNATY® for Covid-19 by Pfizer-BioNTech, - ONPATTRO® for transthyretin amyloidosis by Alnylam Pharmaceuticals, - First in-human proof of concept for genome base editing, and - First personalized CRISPR therapy. Today, Acuitas is advancing next-generation LNP to support a variety of modalities. These therapies include targeted LNP for extrahepatic and in vivo CAR-T cell therapies, epigenetic medicines to modulate gene expression without altering DNA, multivalent infectious disease vaccines, as well as oncology vaccines, including personalized cancer vaccines.
How many employees does Acuitas Therapeutics have?
Acuitas Therapeutics has around 77 employees on LinkedIn.
Where is Acuitas Therapeutics headquartered?
Acuitas Therapeutics is headquartered in Vancouver, British Columbia.
When was Acuitas Therapeutics founded?
Acuitas Therapeutics was founded in 2009.
Build a lead list from companies like Acuitas Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.